Developing effective cancer vaccines presents several challenges. Cancer cells are the body's own cells that have mutated, making it difficult for the immune system to distinguish them from normal cells. Additionally, cancer cells can develop mechanisms to evade the immune system. Another challenge is the heterogeneity of cancer; each patient's cancer may have different mutations and characteristics, making a one-size-fits-all vaccine approach less effective.
